Related Experiment Video
Updated: Aug 9, 2025

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Cardiopulmonary Long-Term Sequelae in Patients after Severe COVID-19 Disease
Julia Hanne Niebauer1, Christina Binder-Rodriguez2, Ahmet Iscel1
1Department of Cardiology, Favoriten Clinic, 1100 Vienna, Austria.
Insights
Long-term effects of severe COVID-19 are common, with most patients experiencing Long-COVID symptoms six months post-discharge. Exertional dyspnea is linked to cardiopulmonary issues, while hospital stay length and ICU admission predict Long-COVID development.
Area of Science:
- Cardiology
- Pulmonology
- Infectious Diseases
Background:
- Severe COVID-19 can lead to persistent health issues, impacting cardiopulmonary function.
- Long-COVID is a recognized post-viral syndrome with diverse manifestations.
Purpose of the Study:
- To investigate long-term cardiopulmonary effects following severe COVID-19.
- To identify predictors of developing Long-COVID.
Main Methods:
- Prospective registry of 150 hospitalized patients, assessed 6 months post-discharge.
- Utilized echocardiography, MRI, pulmonary function tests, and CT scans.
- Clinical follow-up included symptom assessment and biomarker analysis (NT-proBNP).
Main Results:
- 75% met Long-COVID criteria; 49% reported fatigue, 38% exertional dyspnea.
- Cardiopulmonary abnormalities included reduced global longitudinal strain (GLS) (11%), diastolic dysfunction (4%), pericardial effusion (18%), and impaired pulmonary function (11%).
- Exertional dyspnea correlated with impaired pulmonary function, reduced GLS, and/or diastolic dysfunction. Predictors of Long-COVID: longer hospital stay, ICU admission, and higher NT-proBNP.
Conclusions:
- A majority of severe COVID-19 survivors experience Long-COVID symptoms 6 months post-discharge.
- Exertional dyspnea is a key indicator of underlying cardiopulmonary dysfunction.
- Hospitalization duration, ICU stay, and elevated NT-proBNP are significant predictors of Long-COVID.
Abstract:
We aimed to identify cardiopulmonary long-term effects after severe COVID-19 disease as well as predictors of Long-COVID in a prospective registry. A total of 150 consecutive, hospitalized patients (February 2020 and April 2021) were included six months post hospital discharge for a clinical follow-up. Among them, 49% experienced fatigue, 38% exertional dyspnea and 75% fulfilled criteria for Long-COVID. Echocardiography detected reduced global longitudinal strain (GLS) in 11% and diastolic dysfunction in 4%. Magnetic resonance imaging revealed traces of pericardial effusion in 18% and signs of former pericarditis or myocarditis in 4%. Pulmonary function was impaired in 11%. Chest computed tomography identified post-infectious residues in 22%. Whereas fatigue did not correlate with cardiopulmonary abnormalities, exertional dyspnea was associated with impaired pulmonary function (OR 3.6 [95% CI: 1.2-11], p = 0.026), reduced GLS (OR 5.2 [95% CI: 1.6-16.7], p = 0.003) and/or left ventricular diastolic dysfunction (OR 4.2 [95% CI: 1.03-17], p = 0.04). Predictors of Long-COVID included length of in-hospital stay (OR: 1.15 [95% CI: 1.05-1.26], p = 0.004), admission to intensive care unit (OR cannot be computed, p = 0.001) and higher NT-proBNP (OR: 1.5 [95% CI: 1.05-2.14], p = 0.026). Even 6 months after discharge, a majority fulfilled criteria for Long-COVID. While no associations between fatigue and cardiopulmonary abnormalities were found, exertional dyspnea correlated with impaired pulmonary function, reduced GLS and/or diastolic dysfunction.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cardiomyopathy II: Dilated Cardiomyopathy
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Heart Failure III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

